These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15935658)

  • 1. Structural biology of G protein-coupled receptors.
    Lundstrom K
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3654-7. PubMed ID: 15935658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of G protein-coupled receptors as targets in drug discovery.
    Lundstrom K
    IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modelling of drug targets: the past, the present and the future.
    Dahl SG; Sylte I
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):151-5. PubMed ID: 15733208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I want a new drug: G-protein-coupled receptors in drug development.
    Schlyer S; Horuk R
    Drug Discov Today; 2006 Jun; 11(11-12):481-93. PubMed ID: 16713899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed development of drugs acting at family B G protein-coupled receptors.
    Miller LJ
    Ann N Y Acad Sci; 2008 Nov; 1144():203-9. PubMed ID: 19076378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural genomics on membrane proteins: the MePNet approach.
    Lundstrom K
    Curr Opin Drug Discov Devel; 2004 May; 7(3):342-6. PubMed ID: 15216938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling mechanisms of GPCR ligands.
    Strange PG
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):196-202. PubMed ID: 18283607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhodopsin: a structural primer for G-protein coupled receptors.
    Stenkamp RE; Teller DC; Palczewski K
    Arch Pharm (Weinheim); 2005 Jun; 338(5-6):209-16. PubMed ID: 15952240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled time travel: evolutionary aspects of GPCR research.
    Römpler H; Stäubert C; Thor D; Schulz A; Hofreiter M; Schöneberg T
    Mol Interv; 2007 Feb; 7(1):17-25. PubMed ID: 17339603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-mediated activation of heterotrimeric G-proteins: current structural insights.
    Johnston CA; Siderovski DP
    Mol Pharmacol; 2007 Aug; 72(2):219-30. PubMed ID: 17430994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of G protein-coupled receptor modulators: an explanation for the observed class difference.
    Beaumont K; Schmid E; Smith DA
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3658-64. PubMed ID: 15982884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of novel G protein coupled receptors.
    Davies MN; Flower DR
    Methods Mol Biol; 2009; 528():25-36. PubMed ID: 19153682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of GPCR structures in drug design.
    Congreve M; Langmead C; Marshall FH
    Adv Pharmacol; 2011; 62():1-36. PubMed ID: 21907905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
    Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
    Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.